Artificial Tears Market Size & Share Report

1. The global artificial tears market reached $2.64 billion in 2019 and is projected to grow to $4.30 billion by 2027, with a compound annual growth rate of 5.9%. North America dominates with 52.27% market share, driven by robust healthcare infrastructure and high prevalence of dry eye syndrome. Key market developments include:  July 2021: Bausch+Lomb launched Biotrue Hydration Boost lubricant eye drops in the U.S.  April 2021: Alcon introduced Systane Hydration Multi-Dose Preservative-Free lubricant eye drops  October 2019: Allergan released the Refresh Relieva lubricant eye product line Market leaders include:  Allergan (AbbVie Inc.)  Alcon  Santen Pharmaceutical Co., Ltd.  Bausch & Lomb The market growth is driven by:  Increasing prevalence of dry eye syndrome (affecting 9.5-90% of population in various countries)  Rising awareness of ocular diseases  Introduction of advanced eye care products Distribution channels include hospital pharmacies, retail pharmacies, and online pharmacies, with online channels showing strong growth during the COVID-19 pandemic. Report- Fortune Business Insights - Artificial Tears Market Size, Share | Global Industry Report https://www.fortunebusinessinsights.com/artificial-tears-market-103486